StonvexLoading…
StonvexStonvexStonvexCore line items from MNTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $51.88M | $46.43M | $176.38M | $132.99M | $87.73M |
Operating Income | Not available | $-1.60M | $852.00K | $2.50M | $-1.95M |
Net Income | Not available | $5.00K | $1.75M | $-746.00K | $-5.95M |
EPS (Diluted) | $0.00 | $0.00 | $0.01 | $-0.01 | $-0.04 |
Total Assets | Not available | $467.78M | $435.46M | $383.31M | $382.49M |
Total Liabilities | Not available | $204.01M | $172.31M | $122.58M | $127.78M |
Cash & Equivalents | Not available | $25.95M | $23.75M | $6.77M | $29.13M |
Free Cash Flow OCF − CapEx | Not available | $-15.02M | $-86.21M | $-45.11M | $-27.95M |
Shares Outstanding | Not available | 143.24M | 143.24M | 143.16M | 143.10M |